• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AKILIINTERACTIVE LABS, INC. ENDEAVORRX; DIGITAL THERAPEUTIC SOFTWARE FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AKILIINTERACTIVE LABS, INC. ENDEAVORRX; DIGITAL THERAPEUTIC SOFTWARE FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER Back to Search Results
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
Wasn't effective.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDEAVORRX
Type of Device
DIGITAL THERAPEUTIC SOFTWARE FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER
Manufacturer (Section D)
AKILIINTERACTIVE LABS, INC.
MDR Report Key18058641
MDR Text Key327371480
Report NumberMW5147655
Device Sequence Number1
Product Code QFT
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
Report Date 10/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/01/2023
Patient Sequence Number1
Patient SexMale
-
-